Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06976164

Reflexo Therapy for Gestational Diabetes Mellitus

The Effects of Reflexo Therapy of Sole on Gestational Diabetes Mellitus

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Kafrelsheikh University · Academic / Other
Sex
Female
Age
20 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study will be to detect the effects of Reflexo therapy of sole on GDM.

Detailed description

Gestational diabetes mellitus is considered a hazard factor for antenatal complications for both mother and fetus. It is characterized by glucose intolerance of variable degrees with the beginning or first recognition of pregnancy. It affects 14% of pregnancies worldwide, and it undergoes continuous changes in the diagnostic criteria, ethnicity and the population studied. There is an increasing prevalence of diabetes mellitus, and its major metabolic disorder caused by the insulin secretion defect or insulin action defect resulting from a defect in insulin secretion, insulin action, or both. As a result, it will lead to chronic hyperglycemia associated with carbohydrates, protein, and fat disturbance. In spite of the fact that the reason for gestational diabetes mellitus is still not fully understood, it is proposed that human placental lactogen has growth hormone-like actions, and that it causes lipolysis and thus increases the levels of circulating fatty acids that repress the action of insulin and cause insulin resistance in pregnant females which appear to play a crucial role in the pathogenesis of gestational diabetes mellitus.

Conditions

Interventions

TypeNameDescription
PROCEDUREThe standard antenatal care.Antenatal Protocol.
PROCEDUREFoot reflexology.A manual therapy technique.

Timeline

Start date
2025-05-01
Primary completion
2026-01-01
Completion
2026-06-01
First posted
2025-05-16
Last updated
2025-05-16

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06976164. Inclusion in this directory is not an endorsement.